Soy phytoestrogen supplementation and menopause

大豆植物雌激素补充和更年期

基本信息

项目摘要

DESCRIPTION (provided by applicant): Dr. Cynthia K. Sites is an Associate Professor of Obstetrics and Gynecology and Director of the Fellowship Program in Reproductive Endocrinology and Infertility at the University of Vermont College of Medicine. Dr. Sites' major research goal is to understand and develop new therapeutic strategies to alleviate increased cardiovascular disease risk following menopause. This K24 Midcareer Award in Patient-Oriented Research will ensure that Dr. Sites devotes at least 40% of her effort to patient-oriented research and mentoring of clinical investigators. Although Dr. Sites has conducted several patient-oriented research projects toward this goal, this proposal describes Dr. Sites' study, "Soy Phytoestrogens and Metabolic Cardiovascular Risk." Since the publication of the Women's Health Initiative findings, postmenopausal women are discontinuing hormone replacement therapy and considering alternative strategies such as soy phytoestrogens. Our overall hypothesis is that dietary supplementation with soy phytoestrogens improves glucose metabolism by increasing glucose disposal and reducing insulin secretion, which reduce the risk of cardiovascular disease. Fellows to be mentored by Dr. Sites through this K24 award will be trained to develop hypotheses and carry out projects consistent with these goals. The Candidate has demonstrated continued commitment to mentoring and training fellows, residents, and medical students in Patient-Oriented Research, and has the full support of her department and the General Clinical Research Center for this project.
描述(由申请人提供):Cynthia K. Sites 博士是佛蒙特大学医学院妇产科副教授兼生殖内分泌学和不孕不育研究金项目主任。 Sites 博士的主要研究目标是了解和开发新的治疗策略,以减轻更年期后增加的心血管疾病风险。 K24 面向患者的研究中职业生涯奖将确保 Sites 博士将至少 40% 的精力投入到面向患者的研究和临床研究人员的指导上。尽管 Sites 博士已为此目标开展了多个以患者为导向的研究项目,但本提案描述了 Sites 博士的研究“大豆植物雌激素和代谢性心血管风险”。自从《妇女健康倡议》研究结果发表以来,绝经后妇女正在停止激素替代疗法,并考虑采用大豆植物雌激素等替代策略。我们的总体假设是,膳食补充大豆植物雌激素可以通过增加葡萄糖处理和减少胰岛素分泌来改善葡萄糖代谢,从而降低心血管疾病的风险。通过 K24 奖项接受 Sites 博士指导的研究员将接受培训,以提出假设并开展与这些目标一致的项目。 该候选人表现出对以患者为导向的研究方面指导和培训研究员、住院医师和医学生的持续承诺,并得到了她所在部门和综合临床研究中心对该项目的全力支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CYNTHIA K SITES其他文献

CYNTHIA K SITES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CYNTHIA K SITES', 18)}}的其他基金

SOY AND METABOLISM IN MENOPAUSE
大豆与更年期的新陈代谢
  • 批准号:
    7603233
  • 财政年份:
    2007
  • 资助金额:
    $ 13.29万
  • 项目类别:
SOY PHYTOESTROGENS AND METABOLIC CARDIOVASCULAR RISK
大豆植物雌激素与代谢性心血管风险
  • 批准号:
    7378575
  • 财政年份:
    2006
  • 资助金额:
    $ 13.29万
  • 项目类别:
SOY AND METABOLISM IN MENOPAUSE
大豆与更年期的新陈代谢
  • 批准号:
    7380489
  • 财政年份:
    2006
  • 资助金额:
    $ 13.29万
  • 项目类别:
SOY PHYTOESTROGENS AND METABOLIC CARDIOVASCULAR RISK
大豆植物雌激素与代谢性心血管风险
  • 批准号:
    7206955
  • 财政年份:
    2005
  • 资助金额:
    $ 13.29万
  • 项目类别:
Soy phytoestrogen supplementation and menopause
大豆植物雌激素补充和更年期
  • 批准号:
    7409981
  • 财政年份:
    2004
  • 资助金额:
    $ 13.29万
  • 项目类别:
Soy phytoestrogen supplementation and menopause
大豆植物雌激素补充和更年期
  • 批准号:
    7057270
  • 财政年份:
    2004
  • 资助金额:
    $ 13.29万
  • 项目类别:
Soy Phytoestrogens and Metabolic Cardiovascular Risk
大豆植物雌激素与代谢性心血管风险
  • 批准号:
    7041567
  • 财政年份:
    2004
  • 资助金额:
    $ 13.29万
  • 项目类别:
Hormone Replacement Therapy and Metabolic Cardiovascular Risk
激素替代疗法和代谢性心血管风险
  • 批准号:
    7041528
  • 财政年份:
    2004
  • 资助金额:
    $ 13.29万
  • 项目类别:
Soy phytoestrogen supplementation and menopause
大豆植物雌激素补充和更年期
  • 批准号:
    7228990
  • 财政年份:
    2004
  • 资助金额:
    $ 13.29万
  • 项目类别:
Soy phytoestrogen supplementation and menopause
大豆植物雌激素补充和更年期
  • 批准号:
    7100629
  • 财政年份:
    2004
  • 资助金额:
    $ 13.29万
  • 项目类别:

相似海外基金

Understanding causes and consequences of variation in body composition, cardiorespiratory and muscular fitness
了解身体成分、心肺和肌肉健康变化的原因和后果
  • 批准号:
    MR/Y009398/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.29万
  • 项目类别:
    Fellowship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
  • 批准号:
    10674401
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
Effects of daily low oxygen exposure on weight status, body composition, and metabolic health
每日低氧暴露对体重状况、身体成分和代谢健康的影响
  • 批准号:
    10756039
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
  • 批准号:
    22KJ2600
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Differential impacts of water insecurity on diet and body composition throughout the life course
水不安全对整个生命过程中饮食和身体成分的不同影响
  • 批准号:
    10749236
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
Oral Feeding Difficulty in Large for Gestational Age Infants: Defining Interrelationships between Body Composition, Oral Feeding Ability, and Appetite-Regulating Hormones
大胎龄婴儿的经口喂养困难:定义身体成分、经口喂养能力和食欲调节激素之间的相互关系
  • 批准号:
    10734263
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
Staging the host in Cancer: AI-based automated comprehensive body composition assessment for Precision Medicine
对癌症宿主进行分期:基于人工智能的自动化综合身体成分评估,用于精准医学
  • 批准号:
    478392
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
    Operating Grants
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity
bimagrumab 对肥胖成人的身体成分、胰岛素敏感性和骨骼的影响
  • 批准号:
    10716254
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
Relating phthalate and metals exposure during pregnancy and perimenopause to bone health and body composition in midlife
怀孕和围绝经期期间邻苯二甲酸盐和金属暴露与中年骨骼健康和身体成分的关系
  • 批准号:
    10746972
  • 财政年份:
    2023
  • 资助金额:
    $ 13.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了